BiomimX
Developing beating organs-on-chip platforms as in vitro pre-clinical models to improve the drug development process. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$1—2m (Dealroom.co estimates Nov 2022.)
Milan Lombardy (HQ)
- hard tech
- biotechnology
- horizon europe
- woman founder
- spinout
- eit ecosystem
- cardiology
- eit health
- drug development
- seal of excellence ec
- techbio
- eit supernovas
- health it
- health diagnostics
- ai drug discovery
- techbio drug discovery
- headstart (eit health)
- eic
- health information
- regenerative medicine
- headstart 2018 (eit health)
- degenerative diseases
- cardiovascular
- rare diseases
Authorizing premium user...